Delivery Order SPE2DB20D1004-SPE2DB22FF1X9
- Not listed
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $10,800.64. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- This federal contract award is for the delivery of pharmaceutical products, specifically Trelegy Ellipta 100-62.5-25 60S, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,874.69. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to...
- This federal contract award is for the delivery of Trelegy Ellipta pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $5,243.57 and runs through January 26, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp also holds a significant...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,307.48 and an ultimate completion date of February 10, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award is for the pharmaceutical product Trelegy Ellipta, which is being procured by the Defense Logistics Agency (DLA) through a delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,210.02 and a completion date of July 27, 2023. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Trelegy Ellipta 100-62.5-25 60S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $23,865.25 and is a firm fixed price delivery order. It has an ultimate completion date of July 16, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $11,783.89 and an ultimate completion date of November 16, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60s medication to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,649.99 and was awarded on October 8, 2021 with an ultimate completion date of October 12, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,102.50 and an ultimate completion date of August 15, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor to the U.S. federal government. This order is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution firm. The contract has a ceiling value of $8,206.72 and an ultimate completion date of November 7, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF1X9Delivery Order
This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $3,124.39 and is structured as a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the DLA Troop Support Medical is valued at up to $999,999,999.00 and runs through November 2026, serving as a primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The DLA is the funding agency for this contract, which aligns with the agency's role in providing medical and pharmaceutical support to the Department of Defense and other federal entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 2/2/22 |